Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berchou, R. C.
Right arrow Articles by Russell, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berchou, R. C.
Right arrow Articles by Russell, M. E.
NEUROLOGY 1981;31:1483
© 1981 American Academy of Neurology

Clorazepate therapy for refractory seizures

Richard C. Berchou, Pharm.D., Ernst A. Rodin, M.D. and Mary E. Russell, R.N.

Departments of Clinical Pharmacy (Dr. Berchou) and Neurology (Dr. Rodin), Wayne State University, the Neurology Department (Dr. Rodin and Ms. Russell) and EEG (Dr. Rodin), Lafayette Clinic, and the Epilepsy Center of Michigan (Dr. Rodin).

Address correspondence and reprint requests to Dr. Berchou, Assistant Professor, Clinical Pharmacy, Wayne State University, Detroit, MI 48201.

We treated 61 patients with seizures refractory to conventional anticonvulsants by adding clorazepate to their regimen. There was some improvement of seizure control, but no overall improvement in the electroencephalogram. Improvement of seizure control was not significantly related to seizure type. No significant side effects, drug interactions, or laboratory abnormalities were noted with doses up to 3 mg per kilogram per day.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by AAN Enterprises, Inc.